These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 16754296)
41. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer. Whiteaker JR; Zhang H; Zhao L; Wang P; Kelly-Spratt KS; Ivey RG; Piening BD; Feng LC; Kasarda E; Gurley KE; Eng JK; Chodosh LA; Kemp CJ; McIntosh MW; Paulovich AG J Proteome Res; 2007 Oct; 6(10):3962-75. PubMed ID: 17711321 [TBL] [Abstract][Full Text] [Related]
42. High-performance proteomics as a tool in biomarker discovery. Meyer HE; Stühler K Proteomics; 2007 Sep; 7 Suppl 1():18-26. PubMed ID: 17893859 [TBL] [Abstract][Full Text] [Related]
43. Cancer biomarkers: current issues and future directions. Jain KK Curr Opin Mol Ther; 2007 Dec; 9(6):563-71. PubMed ID: 18041667 [TBL] [Abstract][Full Text] [Related]
44. Oncoproteomics: current trends and future perspectives. Cho WC; Cheng CH Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924 [TBL] [Abstract][Full Text] [Related]
45. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions. Jurisicova A; Jurisica I; Kislinger T Expert Rev Proteomics; 2008 Aug; 5(4):551-60. PubMed ID: 18761466 [TBL] [Abstract][Full Text] [Related]
46. Conference report and review: current status of biomarkers potentially associated with prostate cancer outcomes. Flaig TW; Nordeen SK; Lucia MS; Harrison GS; Glodé LM J Urol; 2007 Apr; 177(4):1229-37. PubMed ID: 17382696 [TBL] [Abstract][Full Text] [Related]
47. Beyond PSA: utility of novel tumor markers in the setting of elevated PSA. Lin DW Urol Oncol; 2009; 27(3):315-21. PubMed ID: 19414121 [TBL] [Abstract][Full Text] [Related]
48. Can cancer be diagnosed with a blood test during routine examinations? Weiss PA; Weiss PA Clin J Oncol Nurs; 2007 Dec; 11(6):940-1. PubMed ID: 18063553 [TBL] [Abstract][Full Text] [Related]
50. [Tumor markers. Current knowledge and practical usefulness]. Papaleo G; Sacerdoti G; Zito GA Recenti Prog Med; 1982 Apr; 72(4):504-30. PubMed ID: 6183719 [No Abstract] [Full Text] [Related]
51. Proteomics: new technologies and clinical applications. Latterich M; Abramovitz M; Leyland-Jones B Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654 [TBL] [Abstract][Full Text] [Related]
52. ZnO nanorods-enhanced fluorescence for sensitive microarray detection of cancers in serum without additional reporter-amplification. Hu W; Liu Y; Yang H; Zhou X; Li CM Biosens Bioelectron; 2011 Apr; 26(8):3683-7. PubMed ID: 21354777 [TBL] [Abstract][Full Text] [Related]
53. Future of early detection of lung cancer: the role of mouse models. Shaw AT; Kirsch DG; Jacks T Clin Cancer Res; 2005 Jul; 11(13 Pt 2):4999s-5003s. PubMed ID: 16000603 [TBL] [Abstract][Full Text] [Related]
54. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping. Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472 [TBL] [Abstract][Full Text] [Related]
55. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer. Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732 [TBL] [Abstract][Full Text] [Related]
56. Serum markers for prostate cancer: a rational approach to the literature. Steuber T; O'Brien MF; Lilja H Eur Urol; 2008 Jul; 54(1):31-40. PubMed ID: 18243505 [TBL] [Abstract][Full Text] [Related]
57. Biomarkers in prostate cancer diagnosis and prognosis: beyond prostate-specific antigen. Fradet Y Curr Opin Urol; 2009 May; 19(3):243-6. PubMed ID: 19325493 [TBL] [Abstract][Full Text] [Related]
58. Biomarkers for lung cancer: clinical uses. Greenberg AK; Lee MS Curr Opin Pulm Med; 2007 Jul; 13(4):249-55. PubMed ID: 17534168 [TBL] [Abstract][Full Text] [Related]
59. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways. Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530 [TBL] [Abstract][Full Text] [Related]
60. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer. Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]